Moderna stock: buy or sell
Jan 27th, 2021
Moderna stock brief
- Moderna closed on Tuesday at $151.93 after skyrocketing a 3.35%.
- The price is currently higher than the upper Bollinger band, which usually indicates a short-term correction
- The stock is configuring an uptrend pattern since September 2020, when it bottomed at $54.21. This rally marked a 180.26% gain
- Bank of America posted a neutral rating for Moderna last Friday, forecasting $140.00
Should I buy Moderna stock?
Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $MRNA stock a buy?
In the current situation of Moderna there is just one buy setup eligible:
Uptrend buy setup
Moderna stock is in an uptrend since in September 2020 that so far has marked an amazing 180.00% gain. Price marked a local bottom in this uptrend at $102.66 in late December, and since then it bounced off a 47.99%. Breaking out over $178.50 - it's last top - will be a good entry point if Moderna resumes the uptrend. If you decide to enter this trade, the suggested stop loss is at $160.65
|Buy setup||Buy point||Stop loss||Risk|
|Uptrend buy setup||$178.50||$160.65||10.00%|
Should I sell Moderna stock?
Knowing when to sell a stock is even harder than knowing when to buy it. Trading strategies give us the ability us to avoid impetuous decisions based on our feelings or the noise surrounding the market. Our trading system selects very simple setups to guide us on when is the best moment to sell a stock. Be aware that these setups should not be used for selling short Moderna stock
As a golden rule, you should never hold a trade that leads to greater losses than those expected upon the buy. The timing to sell your stock must always be ruled by the stop-loss (automatic or manual)
Is it time to sell Moderna stock?
In the current situation of Moderna there is not any eligible sell setup, so Moderna stock holders with operations in green can keep their positions
In the last month, 2 analyst ratings were published for Moderna
|Jan 6th, 2021|
|Jan 22nd, 2021|
|Bank of America||Neutral|
Moderna stock analysis
Moderna shares started an uptrend in September 2020, and gained an amazing 180.26%. During this uptrend, the price provided some entry points on the breakouts. Latest pullback was in late December, when price bounced at $102.66. Like in all uptrends, price needs to take breath and now price is moving in a range between $178.50 and $102.66
Supports and resistances
The current resistances are:
The current support levels are:
When the price moves out of the band (above the upper line or below the lower line) it shows that the price action is currently maintaining a very strong momentum and therefore can correct the trend to the average. For this case, the price is over the upper band, meaning a short-term corrective movement (at least) until it is below the band
Relative strength index
The RSI dropped below the overbought level of 70 in early December after just crossing to the overbough zone for 1 day (weak signal). The RSI reading on Tuesday was 67.41. Since that level was lost, Moderna stock dropped a 10.56%
Moderna stock price history
Moderna IPO was on Dec 7th, 2018 priced at $22.00 per share1. Since then, MRNA stock has risen by 590.59%, with an average of 295.30% per year. If you had invested thousand dollars in Moderna stock on Dec 2018, it would have a value of $6,905.91 today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Moderna stock
How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations issue their analysis predicting how a particular stock will performance in the future.
The following table shows the price forecasts published by financial institutions in the last 30 days. If you are a small trader you shouldn't trade based on these price targets.
Averaging all price targets exposed below, the forecasted price for Moderna stock is $155.00. Moderna closed at $151.93 on Tuesday, that is a 1.98% than the target price.
|Brokerage firm||Price target|
|Jan 6th, 2021|
|Piper Sandler||$166.00 → $170.00|
|Jan 22nd, 2021|
|Bank of America||$130.00 → $140.00|
Earnings and financials
Last October, Moderna, Inc. ($MRNA) reported EPS for that poorly undercut Wall St. expectations. Quarterly EPS was $-0.59 per share versus the estimated $-0.43. This Q3 report represents an earnings surprise of -37.21%. Turnover was $157.9 million compared to $77.5 million predicted by analysts.In comparison, the EPS for the same quarter last year was $-0.37, so current EPS means a reduction of -59.46%. Turnover skyrocketed a 826.38% on an annualized basis in the , from $170.5M to $1.6B last quarter.
Moderna ($MRNA) is releasing quarterly earnings report late next February. Market analysts analysts forecast of $-0.30, that is a 49.15% higher than previous quarter.
Please read:The opinions written in this article are personal and should not be followed as recommendations for you to buy or sell stocks. The author of this document does not know the individual scenarios of the reader, his or her financial statements or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Viewpoints are provided for educative motives only
|Tuesday, January 26th, 2021|
|Day range||$145 - $154.55|
|Average true range||$9.91|
|50d mov avg||$125.77|
|100d mov avg||$97.32|
|200d mov avg||$80.45|
|Earnings date||February 24th, 2021|